Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „substrates“
Suchtreffer
Begriffe & Kennungen
Brilique · 4.5 · Ticagrelor is a mild CYP3A4 inhibitor. Co-administration of ticagrelor and CYP3A4 substrates with narrow thera
Eintrag öffnenBrilique · 4.5 · Ticagrelor is a mild CYP3A4 inhibitor. Co-administration of ticagrelor and CYP3A4 substrates with narrow thera
Eintrag öffnenBrilique · 4.5 · Ticagrelor is a mild CYP3A4 inhibitor. Co-administration of ticagrelor and CYP3A4 substrates with narrow thera
Eintrag öffnenBrintellix · 4.5 · Cytochrome P450 substrates In vitro, vortioxetine did not show any relevant potential for inhibition or induct
Eintrag öffnenBrukinsa · 4.5 · 33 The coadministration of oral P-gp substrates with a narrow therapeutic index (e.g., digoxin) should be done
Eintrag öffnenBrukinsa · 4.5 · CYP2C19 substrates
Eintrag öffnenBrukinsa · 4.5 · CYP2C19 substrates
Eintrag öffnenBrukinsa · 4.5 · CYP3A substrates
Eintrag öffnenBrukinsa · 4.5 · CYP3A substrates
Eintrag öffnenBrukinsa · 4.5 · Co-administration with transport substrates/inhibitors
Eintrag öffnenBrukinsa · 4.5 · Co-administration with transport substrates/inhibitors
Eintrag öffnenBrukinsa · 4.5 · The coadministration of oral P-gp substrates with a narrow therapeutic index (e.g., digoxin) should be done wi
Eintrag öffnenCabometyx · 4.5 · P-glycoprotein substrates Cabozantinib was an inhibitor (IC50 = 7.0 μM), but not a substrate, of Pgp transport
Eintrag öffnenCalquence · 4.5 · ACP-5862 may increase exposure to co-administered MATE1 substrates (e.g., metformin) by inhibition of MATE1 (s
Eintrag öffnenCalquence · 4.5 · ACP-5862 may increase exposure to co-administered MATE1 substrates (e.g., metformin) by inhibition of MATE1 (s
Eintrag öffnenCalquence · 4.5 · Acalabrutinib may increase exposure to co-administered BCRP substrates (e.g., methotrexate) by inhibition of i
Eintrag öffnenCalquence · 4.5 · Acalabrutinib may increase exposure to co-administered BCRP substrates (e.g., methotrexate) by inhibition of i
Eintrag öffnenCalquence · 4.5 · CYP3A substrates
Eintrag öffnenCalquence · 4.5 · CYP3A substrates
Eintrag öffnenCalquence · 4.5 · Effect of acalabrutinib on CYP1A2 substrates
Eintrag öffnen